B-701
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for B-701, covering 2017-06-27 to 2020-03-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study of B-701 in Combination With Pembrolizumab in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma [Phase 1, Phase 2]